Day: October 18, 2021

Data from First Phase III Clinical Study of PXT3003 in Charcot-Marie-Tooth Disease Type 1A, the PLEO-CMT Trial, Published in the Orphanet Journal of Rare Diseases

PARIS, FRANCE / ACCESSWIRE / October 18, 2021 / Pharnext SA (FR0011191287 - ALPHA) (the 'Company'), an advanced late-stage clinical...

RepliCel Files Notice of Arbitration against Shiseido Company to Resolve its License Agreement Dispute Regarding its Androgenetic Alopecia Cell Therapy

After several unsuccessful attempts to settle the dispute, RepliCel has filed an arbitration claim seeking Shiseido's full compliance with the...

Differentiated Approach to Chronic Care Management, “Impact by One Medical,” Designed to Deliver Outsized Results for Patients and Employers within Primary Care

One Medical combines longitudinal high-touch care, education and health navigation with an integrated technology platform to help patients manage their...

error: Content is protected !!